Navigation Links
Regeneron Reports First Quarter 2013 Financial and Operating Results
Date:5/3/2013

receivable from Sanofi98,78199,913Deferred tax assets 300,951340,156Property, plant, and equipment, net392,378379,940Other assets117,22079,763Total assets$

2,275,998$

2,080,490LIABILITIES AND STOCKHOLDERS' EQUITYAccounts payable, accrued expenses, and other liabilities$

154,199$

118,604Deferred revenue252,703259,173Facility lease obligations160,480160,810Convertible senior notes302,268296,518Stockholders' equity1,406,3481,245,385Total liabilities and stockholders' equity$

2,275,998$

2,080,490 

TABLE 2REGENERON PHARMACEUTICALS, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)(In thousands, except per share data)Three months endedMarch 31,20132012Revenues:Net product sales$

318,740$

127,931Sanofi collaboration revenue99,27385,005Bayer HealthCare collaboration revenue14,90712,483Technology licensing5,8935,893Other revenue851477439,664231,789Expenses:Research and development180,299138,862Selling, general, and administrative77,26058,428Cost of goods sold29,05512,298286,614209,588Income from operations153,05022,201Other income (expense):Investment income456610Interest expense(11,675)(11,160)(11,219)(10,550)Income before income taxes141,83111,651Income tax expense(42,957)Net income$

98,874$

11,651Net income per share - basic$

1.02$

0.12Net income per share - diluted$

0.90$

0.11Weighted average shares outstanding - basic96,87893,446Weighted average shares outstanding - diluted109,369107,734 TABLE 3REGENERON PHARMACEUTICALS, INC.RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME (Unaudited)(In thousands, except per share data)Three months endedMarch 31,20132012GAAP net income$

98,874$

11,651Adjustments:R&D: Non-cash share-based compensation expense 26,76110,556SG&A: Non-cash share-based compensation expense25,78712,578COGS: Non-cash share-based compensation expens
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
2. Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
3. Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet
4. Regeneron Announces March 2012 Investor Conference Presentations
5. Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference
6. Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
7. Agendia Reports More Than 20,000 MammaPrint Breast Cancer Recurrence Results
8. PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
9. Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development
10. InterMune Reports First Quarter 2013 Financial Results and Business Highlights
11. Cord Blood Banking Industry: 2013 Growth Opportunities Analysis in New Market Research Report at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Md. , March 27, 2015  CASI Pharmaceuticals, ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a commercial focus on ... three and 12 months ended December 31, 2014.  ... ($1.6 million), or ($0.05) per share, for the three ...
(Date:3/26/2015)... 26, 2015 The Market Element LLC, ... strategic alliance with Designing Gig LLC to provide website ... , “Forging this alliance with Designing Gig represents ... can extend a comprehensive, end-to-end, digital solution for our ... execution,” said Chuck Miller, president of The Market Element. ...
(Date:3/26/2015)... ReliantHeart, Inc., an innovative supplier of advanced mechanical ... transit-time flow measurement solutions, are collaborating on a miniature ... the HeartAssist5® Left Ventricular Assist Device (LVAD). ... and peace of mind. , The Transonic flow ... 1/6th of the power required by earlier flow board ...
(Date:3/25/2015)... Agnition announced today that it will ... airing for the first time at 7:30 a.m. CST ... will explore the extremely important role soil microbes perform ... patented Microbial Catalyst™ technology that enhances soil and plant ... will air again on April 28. , A biochemist ...
Breaking Biology Technology:CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2
... NEW YORK, April 29 Lighthouse International is ... are visually impaired and,partially sighted for 103 years., ... and CEO of Lighthouse,International:, "This is a ... other genetic eye diseases that affect children.", ...
... April 29 Abingworth, the,international life sciences investment ... Partner. He will be based at the Company,s,offices ... will be to support,Abingworth,s efforts in growth equity, ... and build-ups in healthcare and life,science companies. Abingworth ...
... DUBLIN and NEW YORK, April 29 , - Announces ... Science Venture Capital ("VC") Fund Launched in Ireland, - ... the Life Science Sector Globally, - ... Capital in Europe With a Primary Focus ...
Cached Biology Technology:Abingworth Appoints David Mayer as Partner 2Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm 2Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm 3Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm 4
(Date:3/5/2015)... PAULO , March 5, 2015 In ... 41 percent of companies already using these solutions and 42 ... 2015. Of the latter, approximately 25 percent of the companies ... While the majority of companies in the region ... anticipated that the hybrid model will command significant attention in ...
(Date:3/3/2015)... , March 3, 2015 Cryoport, ... of advanced cryogenic logistics solutions for the ... stem cells, cell lines, clinical research organizations, ... today announced the expansion of its relationship ... ("Fred Hutch") Clinical Research Division with ...
(Date:3/2/2015)... 2015  Businesses have a new option for ... Rankins Enterprises has announced the launch of a ... for businesses to protect their customers, personal data, ... Beconux is a biometric transaction processing system ... to an ATM machine, the new system fuses ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Personal Data Protection Company Launches New Product 2
... in coral reef science and management will descend upon Australia ... Cairns, gateway to the Great Barrier Reef, on July 9-13. ... event will draw more than 2,000 people from some 80 ... from international experts in coral reef conservation. The research and ...
... - Geology posted ahead of print 14 ... modeling studies of the U.S. New Madrid Seismic Zone; ... investigation of a potential nuclear waste repository site in ... insights from the Mekong River, Vietnam; and an explanation ...
... Modeling biological systems can provide key insights for ... themselves so-called oscillatory systems pose some key ... a new method for estimating the parameters used in ... areas ranging from cancer to fertility. "These oscillatory ...
Cached Biology News:World's leading coral experts to gather in Australia 2Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 2Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 3Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 4Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 5Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 6Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 7Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 8Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 9Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 10Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 11Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 12Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 13Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 14Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 15Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 16Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 17Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science 18New method for estimating parameters may boost biological models 2New method for estimating parameters may boost biological models 3
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... The Fujifilm Life Science LAS-3000 ... technology with a simplified user interface, ... a wide range of modularities. The ... for a wide range of applications ...
... for individual and parallel agitation control ,Single ... DASGIP vessels, featuring range of stirring speeds ... 16 overhead drives can be operated as ... and cellferm-pro® for microbiology and cell culture. ...
The LAS-3000 imaging system combines new CCD camera technology with a simplified user interface to provide significantly improved system sensitivity with a wide range of modularities. This system is...
Biology Products: